CME webinar: 2023 UPMC for Life Medicare Product Training
Jun. 2023Education/Webinars
Please join us for a live, CME-accredited webinar Tuesday, July 11, from 7 a.m. to 8 a.m., that will provide an overview on Medicare.
During this presentation, our expert will discuss:
Presenter:
Register now. This webinar will be recorded.
You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Provider is responsible for verifying CME eligibility.
During this presentation, our expert will discuss:
- The difference between Medicare Fee for Service and Medicare Advantage, why Medicare Advantage exists, and where it’s going in the future.
- The importance of value-based care.
- UPMC Health Plan’s Medicare Advantage Plan, UPMC for Life.
- Care managers and what they do, optimizing information flow.
- Health outcomes, accountability for costs, and why this is a better patient experience.
Presenter:
- Barbara Kevish MD, AVP, Medicare Medical Services, UPMC Health Plan
Register now. This webinar will be recorded.
You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Provider is responsible for verifying CME eligibility.
Recent Announcements
Voluntary nationwide recall: Atorvastatin (Alkem – October)
Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.Nov. 2025Pharmacy Updates
October 2025 UPMC for You and UPMC Community HealthChoices formulary update
Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.Oct. 2025Pharmacy Updates
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates